Laura Greco: Stage IV Lung Cancer

Patient Info: Laura Greco, Female | Stage IV

Biomarkers: ALK translocation / ALK-driven; MET amplification; EGFR amplification reported in brain tumor

Metastatic Site: Brain

Laura Greco passed away on July 14, 2024 after Stage IIIA ALK-driven lung cancer later metastasized to the brain and required repeated brain-directed treatment and targeted therapy.

Lung Cancer Research FoundationRead more →

Stage IV Lung Cancer: Mila's Patient Story

Patient Info: Mila Gardon, Female, 50s | Stage IV

Metastatic Site: Neck lymph nodes; skull; iliac bone

Stage IV lung cancer with spread to neck lymph nodes, skull, and iliac bone responded after cryotherapy and interventional therapy; lung tumors disappeared and tumor marker normalized, but the source does not state full remission or NED.

Stage IV ALK Non-Small Cell Lung Cancer: Linnea's Patient Story

Patient Info: Linnea Olson, Female, 40s | Stage IV

Biomarkers: ALK mutation / ALK-rearranged lung cancer

Metastatic Site: Lungs / intrapulmonary disease

Living long term with Stage IV ALK-positive NSCLC; ALK-targeted clinical trials controlled disease for years but were described as disease control rather than cure.

Massachusetts General HospitalRead more →

EGFR Non-Small Cell Lung Cancer: Donna's Patient Story

Patient Info: Donna Thompson, Female, 40s

Biomarkers: EGFR-positive lung cancer reported during recurrence; initial tumor biomarker status not reported

Recurrent NSCLC after earlier Stage II surgery and limited chemotherapy; later EGFR-targeted therapy caused kidney failure, 2 new spots were radiated in July 2025, and new nodules are under watchful monitoring.

GO2 FoundationRead more →

Stage IV EGFR Non-Small Cell Lung Cancer: Lexi's Patient Story

Patient Info: Lexi, Female, Under 40 | Stage IV

Biomarkers: EGFR exon 20 mutation

Metastatic Site: Bone — left leg and hip

Living with Stage IV EGFR exon 20 metastatic NSCLC involving bone, after chemotherapy, targeted therapy, a drug trial, and surgery to remove the primary lung mass; latest disease-control status is not clearly stated.

Lung Cancer Research FoundationRead more →

Stage III EGFR Non-Small Cell Lung Cancer: Lauren's Survivor Story

Patient Info: Lauren, Female, Under 40 | Stage III

Biomarkers: EGFR mutation

No evidence of cancer on 1-year scan after fertility preservation, chemotherapy, radiation, and removal of half the left lung for Stage III EGFR-mutated lung cancer.

Lung Cancer Research FoundationRead more →

Stage IV EGFR Non-Small Cell Lung Cancer: Bill's Patient Story

Patient Info: Bill, Male | Stage IV

Biomarkers: EGFR exon 21 mutation

Metastatic Site: Spine; brain; hips/bone

Stage IV EGFR exon 21 lung cancer improved in brain and spine on osimertinib, but later lung-mass growth led to clinical-trial treatment; Bill remained active in advocacy and felt positive about progress.

Lung Cancer Research FoundationRead more →

EGFR Non-Small Cell Lung Cancer: Joanne's Patient Story

Patient Info: Joanne, Female, 60s

Biomarkers: EGFR exon deletion 19 mutation

Ongoing care after right upper-lobe resection, 4 rounds of chemotherapy, and daily Tagrisso for EGFR exon 19 deletion lung adenocarcinoma; formal stage is not stated in the story.

Lung Cancer Research FoundationRead more →

EGFR Lung Cancer: Caroline's Patient Story

Patient Info: Caroline, Female

Biomarkers: Germline EGFR T790M mutation

Ongoing surveillance for germline EGFR T790M-associated lung nodules / lung cancer risk after October 2022 surgery and complications; the story does not support Stage IV disease for Caroline.

Lung Cancer Research FoundationRead more →

Stage IV Lung Cancer: Xavier's Patient Story

Patient Info: Xavier Sanders, Male | Stage IV

Metastatic Site: Liver; brain; lymph nodes

Living with Stage IV lung cancer involving lymph nodes, liver, and 20 to 30 brain tumors while advocating for service members and caregiver support; exact treatment regimen is not reported.

Lung Cancer Research FoundationRead more →

Stage I EGFR Lung Adenocarcinoma: Julie's Patient Story

Patient Info: Julie, Female, 40s | Stage I

Biomarkers: EGFR exon 19 deletion

Ongoing care after Stage IB EGFR exon 19 lung adenocarcinoma treated with lower left lobectomy and Tagrisso/osimertinib, with CT and MRI surveillance; no recurrence/NED statement is explicitly provided.

Lung Cancer Research FoundationRead more →

Stage III ROS1 Non-Small Cell Lung Cancer: Wendy's Survivor Story

Patient Info: Wendy, Female | Stage III

Biomarkers: ROS1-positive / ROS1-rearranged

Completed chemoradiation, surgery, and post-surgery radiation for Stage III ROS1-positive NSCLC by January 2017 and later shared a long-term survivor/advocacy story; no explicit NED statement is given.

Lung Cancer Research FoundationRead more →

Stage IV EGFR Non-Small Cell Lung Cancer: Gerri's Patient Story

Patient Info: Gerri, Female | Stage IV

Biomarkers: EGFR-positive / EGFR-mutated

Metastatic Site: Not reported

Living actively with Stage IV EGFR-positive NSCLC after wedge resection and unnamed EGFR-directed targeted therapy, with major hiking and travel goals continuing after diagnosis.

Lung Cancer Research FoundationRead more →

Stage IV KRAS Non-Small Cell Lung Cancer: Maureen's Patient Story

Patient Info: Maureen, Female | Stage IV

Biomarkers: KRAS mutation

Metastatic Site: Not reported

Living with KRAS-mutated Stage IV lung cancer after initial Stage I diagnosis, later surgery, and radiation, while remaining active in KRAS and lung cancer advocacy.

Lung Cancer Research FoundationRead more →

Stage I Lung Cancer: Jennifer's Survivor Story

Patient Info: Jennifer Rosato Perea, Female | Stage I

Cancer-free after February 2022 lower-right-lobe lobectomy for Stage I lung cancer, with no chemotherapy, radiation, or clinical trial treatment needed; returned to running and completed endurance events.

Lung Cancer Research FoundationRead more →

Stage IV ALK Lung Cancer: Duncan's Patient Story

Patient Info: Duncan Edmonstone, Male, 50s | Stage IV

Biomarkers: ALK-positive / ALK+ mutation

Metastatic Site: Brain

Living 6 years after Stage IV ALK-positive lung cancer with brain metastasis, doing well on ongoing alectinib targeted therapy with minimal side effects.

The Christie NHSRead more →

Stage III Lung Adenocarcinoma: Becky's Survivor Story

Patient Info: Becky Manning, Female, 40s | Stage III

After surgery, chemotherapy and 8 months of nivolumab on a clinical trial, Becky was no longer on active treatment, had no evidence of disease, felt well, and returned to MSK every 6 months for follow-up.

Memorial Sloan KetteringRead more →

Lung cancer surgery complicated by a delayed tracheal tear

Patient Info: Anonymized, male, 70+

He died 37 days after lung-cancer surgery following a prolonged postoperative course complicated by bleeding, a tracheal tear and progressive respiratory and hemodynamic deterioration.

PubMed CentralRead more →

Delayed adrenal insufficiency after lung cancer immunotherapy

Patient Info: Anonymized, male, 60s | Stage II

Imaging and bronchoscopy in November 2024 showed no lung-cancer recurrence or metastasis. By June 2026, he had not experienced another adrenal crisis while continuing hormone replacement.

PubMed CentralRead more →

More than 5 years living with metastatic lung adenocarcinoma after stepwise molecular testing

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: HER2 amplification, EGFR L858R mutation, PD-L1 <1%

Metastatic Site: brain, lung

As of April 2026, she remained on gefitinib with no active tumor lesions after complete regression of lung metastases, more than 5 years (66 months) after her original diagnosis.

PubMed CentralRead more →

Unexpected blood vessel connection found during lung cancer surgery

Patient Info: Anonymized, Female, 70+ | Stage I

She recovered from postoperative complications and remained clinically stable at 8-month follow-up.

PubMed CentralRead more →

Lung cancer first discovered after a small-bowel blockage

Patient Info: Anonymized, Male, 50s | Stage IV

Metastatic Site: jejunum|brain|bone

The cancer progressed to the brain and spine despite chemotherapy, and he was admitted to palliative care.

PubMed CentralRead more →

Long-term lung cancer control after immunotherapy-related diabetes

Patient Info: Anonymized, Male, 70+ | Stage IV

Biomarkers: PD-L1 80%; EGFR, ALK, ROS1 and BRAF negative

Metastatic Site: brain|liver

After years of disease control off pembrolizumab, a new brain lesion appeared in December 2025 and was treated with focused radiation. He remained clinically stable under oncology follow-up.

PubMed CentralRead more →

Dave Bjork’s Stage 1 Lung Cancer Story

Patient Info: Dave Bjork, Male | Stage I

Dave survived more than 20 years after surgery for stage I lung cancer and became an advocate for early detection, screening and inclusion of early-stage survivors.

The Patient StoryRead more →